tm
Seeing Is Believing
tm
Seeing Is Believing
PNT is currently covered by 10 analysts with an average price target of $16.95. This is a potential upside of $4.45 (35.6%) from yesterday's end of day stock price of $12.5.
POINT Biopharma Global's activity chart (see below) currently has 3 price targets and 26 ratings on display. The stock rating distribution of PNT is 73.91% BUY and 26.09% HOLD.
Analysts average stock forecasts to be materialized ratio is 35% with an average time for these price targets to be met of 75.5 days.
Highest price target for PNT is $14, Lowest price target is $12.5, average price target is $16.95.
Most recent stock forecast was given by KEMP DOLLIVER from BROOKLINE on 21-Dec-2023.
Currently out of the existing stock ratings of PNT, 17 are a BUY (73.91%), 6 are a HOLD (26.09%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
12.5
27
3 months 29 days ago
1/3 (33.33%)
$0.03 (0.24%)
5
Hold
12.5
17
5 months 26 days ago
1/3 (33.33%)
$-0.16 (-1.26%)
55
Hold
13
6 months 13 days ago
2/2 (100%)
$3.73 (40.24%)
156
Hold
22
6 months 15 days ago
0/1 (0%)
$13.49 (158.52%)
Hold
12.5
14
6 months 15 days ago
2/3 (66.67%)
$0.1 (0.81%)
199
What is PNT (POINT Biopharma Global) average time for price targets to be met?
Which analyst has the current highest performing score on PNT (POINT Biopharma Global) with a proven track record?
Which analyst has the most public recommendations on PNT (POINT Biopharma Global)?
Which analyst is the currently most bullish on PNT (POINT Biopharma Global)?
Which analyst is the currently most reserved on PNT (POINT Biopharma Global)?
